No HER2 expression Age Tumor size (Invasive lesion) Pathological type N stage Abxtiter (PBS) Abxtiter (CH401MAP) HLA A
1 HD 27       1.377 3.39 A*26:01 A*33:03
2 HD 35       1.032 2.289 A*11:01 A*24:02
3 HD 41       2.653 2.08 A*02:01 A*02:06
4 HD 27       2.94 1.928 A*24:02 A*26:03
5 HD 24       3.789 3.167 A*02:01 A*24:02
6 HD 37       0.877 2.251 A*02:01 A*02:06
7 HD 22       1.242 0.893 A*02:06 A*24:02
8 HD 21       1.166 2.499 A*02:06 A*24:02
9 HD 31       8.542 4.659 A*02:07 A*11:01
10 HD 42       6.487 5.422 A*02:06 A*11:01
11 0 74 10x3 IDC 0 33.073 7.474 A*26:01 A*31:01
12 0 47 10x4 IDC 0 3.907 4.024 A*02:01 A*26:01
13 0 48   DCIS 0 6.328 3.708 A*11:01 A*24:02
14 0 48 4 DCIS mi inva. 0 4.495 3.476 A*02:10 A*24:02
15 0 70 30x15 IDC 0 3.245 3.786 A*02:01 A*24:02
16 0 26 25x25 IDC 0 13.779 12.706 A*02:01 A*31:01
17 0 57 2x3.3 IDC 0 16.207 14.181 A*24:02 A*33:03
18 0 51 23x20 IDC 0 15.598 12.941 A*11:01 A*31:01
19 0 72 15x22 IDC 1 17.539 13.779 A*11:01 A*24:02
20 0 74 30x23 IDC 1 17.265 13.985 A*31:01 -
21 0 45   DCIS 0 22.679 21.379 A*11:01 A*24:02
22 1+ 48 15x13 IDC 0 8.243 10.207 A*02:06 A*31:01
23 1+ 50 20x10 ILC 0 8.013 5.302 A*24:02 -
24 1+ 43   DCIS 0 18.784 13.611 A*11:01 A*24:20
25 2+ 40 10x10 IDC 0 20.47 14.787 A*02:01 A*24:02
26 1+ 46 4x3 IDC 1 22.842 17.851 A*24:02 A*31:01
27 2+ 47   DCIS 0 13.479 13.444 A*02:06 A*11:01
28 1+ 46 10x8 IDC 0 14.922 11.567 A*02:06 A*24:02
29 1+ 46   DCIS 0 19.063 14.652 A*02:01 A*24:02
30 3+ 51 25x20 IDC 1 7.651 11.265 A*11:01 A*24:02
31 3+ 41 15x10 IDC 0 7.587 10.121 A*02:01 A*24:02
32 3+ 65   DCIS 0 8.28 10.963 A*11:01 A*24:02
33 3+ 61 15x14 IDC 0 13.115 12.137 A*24:02 A*31:01
34 3+ 64 40x40 IDC 0 14.961 11.4 A*02:06 A*24:02
35 3+ 75 15x15 IDC 1 13.117 9.002 A*02:07 A*11:01
36 3+ 61 10x8 DCIS mi inva. 0 66.892 58.129 A*02:06 A*24:02
37 3+ 34   DCIS 0 84.442 47.877 A*02:01 A*33:03
38 3+ 51 2.5x2.5 IDC 1 13.779 15.666 A*11:01 A*24:02
39 3+ 68 10x9 IDC 0 18.271 15.564 A*02:01 A*33:03
40 3+ 53 49x20 IDC 0 21.52 16.309 A*02:06 A*31:01
41 3+ 75 80x50 IDC 0 15.406 14.654 A*26:01 A*11:01
Table 2: Clinical characteristics and HLA types.